The Different Predictive Effects of Multiple Body Fat Indexes on Metabolic Dysfunction-Associated Fatty Liver Disease
Introduction In 2022, an international panel of experts redefined non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD).1 The prevalence of MAFLD is approximately 25% globally, affecting an estimated 173 …